Moderna Correlations
| M1RN34 Stock | BRL 12.05 0.04 0.33% |
The current 90-days correlation between Moderna and Vertex Pharmaceuticals Incorporated is 0.05 (i.e., Significant diversification). The correlation of Moderna is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Moderna Correlation With Market
Significant diversification
The correlation between Moderna and DJI is 0.05 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Moderna and DJI in the same portfolio, assuming nothing else is changed.
Moderna |
The ability to find closely correlated positions to Moderna could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Moderna when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Moderna - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Moderna to buy it.
Moving together with Moderna Stock
Moving against Moderna Stock
| 0.9 | JPMC34 | JPMorgan Chase | PairCorr |
| 0.89 | M1UF34 | Mitsubishi UFJ Financial | PairCorr |
| 0.84 | NMRH34 | Nomura Holdings | PairCorr |
| 0.82 | S1MF34 | Sumitomo Mitsui Financial | PairCorr |
| 0.75 | H1DB34 | HDFC Bank Limited | PairCorr |
| 0.72 | TSMC34 | Taiwan Semiconductor | PairCorr |
| 0.65 | SNEC34 | Sony Group Split | PairCorr |
| 0.57 | TMCO34 | Toyota Motor | PairCorr |
| 0.49 | VRTX34 | Vertex Pharmaceuticals | PairCorr |
| 0.38 | B1NT34 | BIONTECH SE DRN | PairCorr |
| 0.93 | MSBR34 | Morgan Stanley | PairCorr |
| 0.9 | HONB34 | Honeywell International | PairCorr |
| 0.89 | SSFO34 | salesforce inc | PairCorr |
| 0.89 | CAON34 | Capital One Financial | PairCorr |
| 0.88 | VISA34 | Visa Inc | PairCorr |
| 0.88 | P2LT34 | Palantir Technologies | PairCorr |
| 0.84 | GGBR3 | Gerdau SA | PairCorr |
| 0.81 | COWC34 | Costco Wholesale | PairCorr |
| 0.8 | WALM34 | Walmart | PairCorr |
| 0.79 | TSLA34 | Tesla Inc | PairCorr |
| 0.79 | PSSA3 | Porto Seguro SA | PairCorr |
| 0.78 | A1VB34 | AvalonBay Communities | PairCorr |
| 0.78 | AMZO34 | Amazon Inc | PairCorr |
| 0.76 | AIRB34 | Airbnb Inc | PairCorr |
| 0.74 | ACNB34 | Accenture plc | PairCorr |
| 0.69 | AAPL34 | Apple Inc | PairCorr |
| 0.64 | MSFT34 | Microsoft | PairCorr |
| 0.55 | RCSL4 | Recrusul SA | PairCorr |
| 0.48 | A1VY34 | A1VY34 | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Moderna Stock performing well and Moderna Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Moderna's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| N1VO34 | 2.06 | (0.44) | 0.00 | 0.85 | 0.00 | 3.49 | 10.24 | |||
| VRTX34 | 1.48 | (0.11) | 0.00 | (0.10) | 0.00 | 2.93 | 19.04 | |||
| M1RN34 | 2.77 | (0.66) | 0.00 | (3.15) | 0.00 | 5.45 | 15.77 | |||
| B1NT34 | 2.05 | 0.16 | 0.05 | 0.31 | 2.60 | 5.30 | 13.89 | |||
| B1GN34 | 1.57 | (0.03) | 0.00 | 5.02 | 0.00 | 3.97 | 20.13 | |||
| T1CH34 | 1.60 | 0.22 | 0.05 | 2.03 | 1.85 | 4.48 | 30.78 | |||
| A1SN34 | 0.40 | 0.00 | 0.00 | 0.01 | 0.00 | 0.25 | 13.57 | |||
| BIOM3 | 2.18 | (0.42) | 0.00 | (0.45) | 0.00 | 5.34 | 15.51 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Moderna without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Moderna Corporate Management
Elected by the shareholders, the Moderna's board of directors comprises two types of representatives: Moderna inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Moderna. The board's role is to monitor Moderna's management team and ensure that shareholders' interests are well served. Moderna's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Moderna's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shannon Klinger | Chief Sec | Profile | |
| James Mock | Chief Officer | Profile | |
| Stephane Bancel | CEO Director | Profile | |
| John Reynders | Chief Officer | Profile | |
| Jerh Collins | Chief Officer | Profile | |
| Lavina CFA | VP Relations | Profile | |
| Juan Andres | Pres Expansion | Profile |